Old Web
English
Sign In
Acemap
>
authorDetail
>
Ibdihaj Fughhi
Ibdihaj Fughhi
Rush University Medical Center
Pathology
Medicine
non-small cell lung cancer (NSCLC)
Bevacizumab
Biomarker (medicine)
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Changes in skeletal muscle mass during PD-1 and PD-L1 checkpoint inhibitor therapy in advanced-stage non-small cell lung cancer patients.
2019
Journal of Clinical Oncology
Maneet Multani
Imad Tarhoni
Ibdihaj Fughhi
Sanjib Basu
Marta Batus
Philip Bonomi
Mary J. Fidler
Jeffrey A. Borgia
Palmi Shah
Show All
Source
Cite
Save
Citations (0)
Differences in circulating angiogenic biomarkers as prognosticator for outcome in bevacizumab-treated nonsquamous non-small cell lung cancer (NSCLC) patients.
2014
Journal of Clinical Oncology
Marta Batus
Ravi Pithadia
John C. Kubasiak
Cristina Fhied
Zahraa Ibrahem
Shruthi Melinamani
Ibdihaj Fughhi
Wen-Rong Lie
Sanjib Basu
Mary J. Fidler
Philip Bonomi
Jeffrey A. Borgia
Show All
Source
Cite
Save
Citations (2)
1